FDA granted accelerated approval to Ibrance (palbociclib) to treat metastatic breast cancer.
FDA granted priority review to Yondelis (trabectedin) for the treatment of patients with advanced soft tissue sarcoma, including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
CANDACE JOHNSON was named the 15th president and CEO of Roswell Park Cancer Institute. Johnson will be the first female leader for the 117-year-old comprehensive cancer center.
FDA approved the Koning Breast CT system and KBCT-guided biopsy bracket. KBCT is intended to provide three-dimensional images for diagnostic imaging of the breast.
The Myeloma Crowd Research Initiative is accepting research proposals for high-risk multiple myeloma until the end of February, through the Myeloma Crowd website. The Myeloma Crowd is a division of the CrowdCare Foundation.
A year after it announced its decision to stop tobacco sales, CVS Health released data that shows how its stores are working to deliver the anti-smoking message.
New data projects that an $18 billion increase in funding per year by the international community could result in a 30 percent reduction in cancer deaths in low- and middle-income countries by 2030.
FDA Commissioner Margaret Hamburg announced that she will be stepping down at the end of March 2015.
NIH would receive a $1 billion funding boost in President Barack Obama's $4 trillion 2016 budget—a 3 percent increase—should Congress pass his proposal.
Computed tomography screening has become a benefit for Americans covered by Medicare. The Centers for Medicare and Medicaid Services Feb. 5 published a final decision to cover screening of current and former smokers, provided they meet stringent eligibility criteria. Beneficiaries will go through counseling, health professionals will be required to provide documentation that “shared decision-making”... […]
